Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer

Abstract Background The effects of gut microbiota and metabolites on the responses to immune checkpoint inhibitors (ICIs) in advanced epidermal growth factor receptor (EGFR) wild-type non-small cell lung cancer (NSCLC) have been studied. However, their effects on EGFR-mutated (EGFR +) NSCLC remain u...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Ming-Yi Yang, Jia-Qi Liu, Jing-Yan Xu, Xiao-Rong Yang, Ri-Wei Zhong, Li-Bo Tang, Lin-Xi Yin, Yu Deng, Ying-Long Peng, Chang Lu, Bao-Long Chen, Dong-Xian Ke, Hai-Yan Tu, Jin-Ji Yang, Chong-Rui Xu, Yi-Long Wu, Qing Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-04-01
Colecção:	Journal of Translational Medicine
Assuntos:	Non-small Cell Lung Cancer Epidermal growth factor receptor Gut microbiota Metabolites Antibiotics
Acesso em linha:	https://doi.org/10.1186/s12967-024-05135-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!